Increased physical activity (PA) is associated with the prevention and delayed onset of many noncommunicable chronic conditions, such as heart disease, diabetes, and cancer, and health benefits, for example reduced risk of disease progression, secondary chronic conditions, and mortality, for individuals with chronic conditions. 1 PA is also associated with reduced cognitive dysfunction and functional limitations and enhanced mental health and quality of life. 2 Thus, identifying strategies to increase activity in high-risk individuals, as in those with at least one major risk factor, and those with chronic conditions remains a priority.
INTRODUCTION
Increased physical activity (PA) is associated with the prevention and delayed onset of many noncommunicable chronic conditions, such as heart disease, diabetes, and cancer, and health benefits, for example reduced risk of disease progression, secondary chronic conditions, and mortality, for individuals with chronic conditions. 1 PA is also associated with reduced cognitive dysfunction and functional limitations and enhanced mental health and quality of life. 2 Thus, identifying strategies to increase activity in high-risk individuals, as in those with at least one major risk factor, and those with chronic conditions remains a priority.
An abundance of technological devices exist to collect and analyze PA data and support the health of high-risk individuals and those with chronic conditions. Devices that are worn on the person, consumer-targeted, and worn continuously to quantify motion during the 24 hour day offer many promising opportunities to advance chronic disease research and clinical practice. These "wearables" include fitness bands, smart watches, and jewelry that log users' activity metrics (i.e., step counts, energy expenditure) plus a range of other physiological and behavioral factors and can be used with a tablet/smartphone app or website that provides users with a summary of collected data. Wearables are designed and marketed as tools to motivate users to increase PA to improve health by allowing them to easily self-monitor behavior, a key element to successful behavior change. 3 In 2013, 84 million wearables were sold; one in ten Americans own a device 4 and annual sales are projected to be >$50 billion by 2018. 5 This burgeoning industry has been met with both excitement and skepticism. Wearables represent a scalable opportunity to collect activity data in free-living conditions, unobtrusively, with greater frequency, lower cost, and higher volume than ever before. 6 Wearables have significant potential to facilitate improvements in health behaviors. However, their capacity to translate external motivations into internal ones for sustainable behavioral changes and clinical value is still unknown. 3 This article aims to: (1) summarize current and potential uses for wearables; (2) discuss challenges to using wearables; and (3) identify future directions for researchers and clinicians for chronic disease prevention and management.
CURRENT AND POTENTIAL USES FOR WEARABLES IN CHRONIC DISEASE PREVENTION AND MANAGEMENT
Studies suggest wearables have adequate validity and reliability for activity measurement, use in chronic disease populations is feasible, and most individuals are open to sharing device data with researchers and healthcare systems. 7, 8 Thus, this is an opportune time to integrate wearables into diverse contexts. Table 1 details potential uses for wearable-derived data for chronic disease research and management within two domains: epidemiological and health promotion.
Epidemiological
Epidemiological uses of wearables for chronic disease development and management include: monitoring activity; describing activity context and correlates; and tracking individual disease trajectories (e.g., return to activity post-surgery).
Epidemiological studies typically rely on self-reported PA estimates, which, generally, have low to moderate validity. 9 Over the past decade, the introduction of accelerometers, valid and reliable tools for measuring activity, 10 into epidemiological studies has provided finegrained data on individual movement patterns. However, limited battery capacity results in short, "snapshot" monitoring periods, typically 7 days. Because fluctuations in activity across weeks and months are not captured, information is missed that may be important when planning to intervene. Wearables can be recharged by the user or have coin cell batteries (last ≥ 12 months) translating to continuous, objective, real-time activity data can be collected over longer time periods resulting in greater insight into activity patterns across time. Finally, although data extracted from most wearables (via the application programming interfaces developed by device manufacturers) is crude compared with data extracted from research grade accelerometers, wearables exhibit adequate validity in comparison with research-grade monitors 11 and are more cost efficient making them an attractive alternative for larger studies. Total duration and activity accrual patterns likely vary over the course of disease progression or treatment. Wearables can be used across different chronic disease trajectory phases (e.g., pre-versus post-surgery) and linked to medical record data to obtain granular data on how activity frequency, intensity, and duration changes over the disease course and with different treatments. These data could be used to identify crucial intervention time points.
Understanding who is likely to be physically active in different contexts is key to any successful intervention. Wearables provide an opportunity to better understand PA determinants and preferences in real-world settings over chronic conditions' trajectories to identify specific intervention targets. Combining wearable data with clinical data, patientreported outcomes (i.e., motivation, symptoms), remote monitoring sensors (i.e., GPS, blood pressure, glucose, body weight), and social media data collected using Ecological Momentary Assessment methodology could provide a more comprehensive, multidimensional understanding of PA across the disease continuum. Ecological Momentary Assessment involves repeated sampling of subjects' current behaviors and experiences in real time in subjects' natural environments. Analysis of these data highlights individual differences in behavior, their distribution over time, factors affecting behavior and the mutual associations between them. 11 Combining wearable data with Ecological Momentary Assessment data from these other sources could provide more accurate information about activity fluctuations' antecedents and outcomes and new insight into potential intervention timing, targets, and high-risk subgroups. For example, these methods could reveal individuals engage in less activity on days they report greater fatigue. Thus, researchers may want to design interventions to increase activity and reduce fatigue.
Little is known about how activity patterns before, during, and after medical treatments predict health outcomes. As daily activity may be a proxy of overall health and functioning, 12 granular data from wearables could be combined with clinical (i.e., hospitalizations, disease progression markers) or functional (i.e., fitness, strength, balance) data to identify onset of disease or functional limitations prior to clinical symptoms. For example, activity may decline prior to hospitalization or with disease complication (i.e., edema, neuropathy) onset. Activity patterns may also be an indicator of symptoms, treatment adherence and short-and long-term disease prognosis. 13 Activity may decline more rapidly prior to disease onset or in individuals with a more aggressive disease. Changes in activity may also be indicative of treatment-related side effects resulting in poorer treatment adherence. Consequently, PA data from wearables could be used to monitor disease onset, treatment adherence, and predict prognostic outcomes amongst high-risk and chronic disease populations in the hospital and outpatient setting.
To date, machine learning algorithms have been developed to predict functional status including post-surgery body area changes in movement, walking stability, gait speed, and fall detection 14 using research-grade accelerometer and gyroscope data. As wearables' storage capacity increases, more data could be collected and used to refine algorithms to track high-risk individuals and identify activity patterns changes indicative of increased complications, more rapid disease progression, poor treatment adherence or disease selfmanagement. Finally, combining wearables, clinical, and functional data with biological datasets (e.g., genomewide association study data; NIH precision medicine initiative) could provide greater insight into interactions between genetics and behavior in disease onset and progression.
Health Promotion
A review of behavior change techniques in 13 wearables and their associated mobile apps 15 found they use many of the same techniques employed in typical PA behavior change interventions (i.e., self-monitoring, goal-setting, social support). Additionally, individuals with chronic conditions perceive wearables as useful and acceptable. 16 Thus, wearables may be a low-cost, feasible, and accessible way for promoting PA. However, most existing efficacious wearables studies provide other behavior change supports including social support, financial incentives, and health coaching. 17 Hence, wearables' ability, alone, to produce clinically meaningful, sustained changes in activity without external motivation and accountability (e.g., reporting progress to study team) in high-risk individuals and those with chronic conditions, is unknown. 3 This is similar to the limited efficacy of providing a scale without additional support for weight loss. Wearables integration within a theory-driven intervention strategy should be carefully considered as wearables, by themselves, will not work for all individuals for a variety of reasons (i.e., demographics, psychosocial factors, motivation) and may need to be combined with additional intervention components. Adopting a stepped-care approach to provide additional intervention tools and supports to those who need them may be necessary to observe meaningful, sustained behavior change.
Cancer Prevention and Control Case Study
Wearables could be implemented and integrated into clinical practice as a monitoring and intervention tool. Table 2 provides example research questions and clinical implications of answering these questions across the themes addressed within this section using cancer prevention and control as a case study. Briefly, wearables may allow for more personalized care and targeted interventions delivered with optimal timing to improve health and quality of life for high-risk individuals and those with chronic conditions.
Challenges and Future Directions
Significant work is needed to understand the best and most efficient ways to fully integrate wearables into care (Table 3) . However, in the future it is possible that wearables data are able to be used in conjunction with other data sources to increase PA, improve health and disease outcomes, and reduce healthcare costs. Figure 1 depicts what this ideal could look like. The relationships between activity data obtained from wearables and data related to disease progression, intermediary endpoints and disease outcomes obtained from other data sources could be integrated and examined unidirectionally and bidirectionally by individual characteristics to identify high-risk individuals for early intervention. These big datasets could be used to create more precise and effective multi-level (i.e., individual, systems wide) PA interventions with oversight from clinical and research staff to increase activity, improve health and disease outcomes and lower healthcare costs for high-risk individuals and those with chronic conditions. stakeholders from the outset can help circumvent many challenges. Understanding individual patient perspectives on the burden of intensive data collection methods is important. Further, understanding clinicians' interest in wearable data and preferences for data presentation is necessary. Wearables developers should also be engaged, in the event activity output or algorithms are needed. Finally, researchers should work with health information specialists and statisticians to develop methods to integrate and harmonize data from wearables and other sources and sensors.
An important challenge is how to derive meaningful outcomes from wearables data, alone, and combined with other data sources to inform clinical decision making. Currently, machine learning approaches are being employed to make sense of the large data volume from wearables using research-grade devices primarily under controlled laboratory conditions. The next step is applying algorithms to free-living data from commercially available devices. This will support intervention research and the ability to understand the magnitude of changes in PA observed via wearables needed for health improvements.
Understanding how to use data from wearables to monitor and predict PA and disease or condition onset will create innumerable opportunities to provide patients with proactive interventions to prevent disease, reduce severity or control progression to a clinical syndrome. Building methods for just-in-time adaptive interventions to intervene on activity in real time based on patient profiles, real-world triggers (i.e., proximity to gyms), patientreported outcomes (i.e., high fatigue, low motivation) or activity data itself (i.e., not meeting activity threshold by noon) should be a priorty. 18 Additionally, innovative study designs including single case designs, multiphase optimization strategy, 19 and sequential multiple assignment designs 19 should be used to identify and adapt the most effective PA intervention components, or component sequence, to understand what works for whom, in what contexts, for what outcomes. Finally, dynamic systems modeling methods can help maximize just-intime adaptive interventions delivery and make better use of intensive longitudinal data from wearables combined with potential intervention mediators. 20 
CONCLUSIONS
Wearables offer an unobtrusive way to collect rich data on PA. These data can be linked to other data sources and used to help monitor and promote activity behavior change and maintenance. Despite wearables' promise, many questions and challenges need to be overcome (Tables 2 and 3 ) before they can be leveraged to enhance clinical care and improve health outcomes in high-risk individuals and those with chronic conditions. Studies using innovative methodology to understand whether these devices can be used for the purposes discussed are needed. Further, engaging diverse researchers (i.e., exercise science, public health, bioinformatics, statistics, methodology) and stakeholders (i.e., patients, clinicians, electronic health record and wearable companies' representatives) to understand challenges with using wearables and discover solutions is important. Ultimately, addressing these issues is central to leveraging wearables to improve public health, clinical care, and health outcomes and reduce disease risk, burden, and healthcare costs. 
2
More personalized treatment decisions.
3
More accurate predictions of treatment side effects or outcomes.
4
More accurate prediction of disease prognosis.
5
Targeted interventions could be developed/delivered to those at highest risk.
6
Specific factors that may impact PA (i.e., fatigue, depression) could be identified and treated.
PA promotion 1 Does giving a high-risk individual a wearable device prevent or delay disease onset?
2
Could wearable PA data be used to predict cancer diagnosis prior to onset of clinical symptoms?
3 Does giving cancer patients undergoing treatment wearables devices reduce typically observed activity decline?
4 Does giving cancer patients undergoing treatment wearable devices improve their health outcomes?
5
What is the optimal timing to give a patient a wearable device?
1 Wearable devices could be given to high-risk individuals to help them maintain or increase PA.
2
Wearables could be given to cancer patients to help them maintain or increase their PA depending on treatment time point.
3
Data from wearables could be integrated into patient charts so clinicians could follow-up with them and check-in on their progress.
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